rs104886440
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_033380.3(COL4A5):c.687+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_033380.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Alport syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
- X-linked Alport syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL4A5 | ENST00000328300.11 | c.687+1G>A | splice_donor_variant, intron_variant | Intron 12 of 52 | 1 | NM_033380.3 | ENSP00000331902.7 | |||
| COL4A5 | ENST00000361603.7 | c.687+1G>A | splice_donor_variant, intron_variant | Intron 12 of 50 | 2 | ENSP00000354505.2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Canonical splice site variant predicted to result in in-frame deletion within a critical region. Variant damages or destroys the canonical splice donor site in intron 12, and is expected to cause abnormal gene splicing; if the splice outcome is exon skip, the loss of the encoded residues in the triple helical region is expected to disrupt normal protein folding and function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 25381091, 28844315, 8738805, 34215756, 19919694) -
Alport syndrome Pathogenic:1
This patient is heterozygous for a known pathogenic variant, c.687+1G>A, in the COL4A5 gene. This variant is predicted to abolish the consensus donor splice site at c.687 and is likely to result in the skipping of exon 12. This splice site variant is listed twice in the COL4A5 Alport database, (http://www.arup.utah.edu/database/ALPORT/ALPORT_display.php).One of the reports in the database was by Lemmink et al 1997 (Hum. Mutat. 9:477-499) who lists an individual with renal failure at 30 years of age. Lin et al (2014 BMC Nephrol 15:175) also reports this variant segregating with disease in a family with multiple affected individuals. The authors comment that the disease in this family was unusually severe in the female patients and unusually mild in the male patient and suggests this maybe due to variable X-chromosome inactivation. -
X-linked Alport syndrome Pathogenic:1
PVS1:Null variant in the gene with established LOF as a disease mechanism PM2:not found in gnomAD PP3:Multiple lines of computational evidence support a deleterious effect on the gene or gene product -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at